Emcure Pharmaceuticals (EMCURE) — Sustainability Report

📢 Key Event
Emcure submits BRSR report to stock exchanges

💡 Investor Takeaway
Emcure demonstrates strong ESG integration with measurable progress in emissions reduction and water management, but faces material transition risks requiring ongoing investment.

Emcure Pharmaceuticals Limited submitted its Business Responsibility and Sustainability Report for FY 2025-26 to stock exchanges, detailing ESG performance across environmental stewardship, social initiatives, and governance. The report highlights an 8.5% reduction in Scope 2 GHG emissions, 50.26% export contribution, and 91% employee training coverage on ESG principles. It outlines material risks including energy transition costs and water scarcity, while noting ZLD implementation and renewable energy investments. Governance disclosures include board-level oversight and third-party assurance by TÜV Rheinland. The filing underscores Emcure's commitment to sustainable growth, stakeholder engagement, and compliance with SEBI's BRSR framework.

📄 View Original Announcement (PDF)

📊 Stock Analysis — EMCURE ✨ Ask AI About This

About Emcure Pharmaceuticals Ltd (EMCURE)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹35,011.16 Cr P/E: 34.6 ROE: 22.9% ROCE: 29.7% Div Yield: 0.20%

View full EMCURE stock details →

📡 Get AI alerts when EMCURE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track EMCURE — Free

💡 Ask AI about this filing

"How will Emcure achieve carbon neutrality targets?" "What is the financial impact of 50% export dependence?" "How does Emcure mitigate supply chain ESG risks?"

Ask AI Free →

📊 More EMCURE filings

See all EMCURE filings →

🔥 Also filed on 28 August 2026

BLIL Balmer Lawrie Investment Ltd Annual Report 520075 Samkrg Pistons & Rings Ltd Annual Report 507998 Simmonds Marshall Ltd Annual Report BLUEDART Blue Dart Express Ltd Annual Report TTL T T Ltd Insider Trading LTF L&T Finance Ltd Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when EMCURE files new disclosures

Track EMCURE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track EMCURE — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd